Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts

被引:0
|
作者
Jane R Noble
Ze-Huai Zhong
Axel A Neumann
John R Melki
Susan J Clark
Roger R Reddel
机构
[1] Children's Medical Research Institute,
[2] Sydney Cancer Centre,undefined
[3] Medical Foundation Building,undefined
[4] K25,undefined
[5] University of Sydney,undefined
来源
Oncogene | 2004年 / 23卷
关键词
telomerase; hTERT; immortalization; p16INK4a; CDKN2A; TP53;
D O I
暂无
中图分类号
学科分类号
摘要
Exogenous expression of the catalytic subunit of telomerase, hTERT, in a normal human foreskin fibroblast cell strain resulted in telomerase activity and an extended proliferative lifespan prior to a period of crisis. Three immortalized cell lines with stably maintained telomere lengths were established from cells that escaped crisis. Each of these cultures underwent a significant downregulation of p16INK4a expression due to gene deletion events. One cell line also acquired mutations in both alleles of the p53 tumor suppressor gene. Downregulation of p16INK4a and loss of wild-type p53 expression occurred after escape from crisis, so these mutations are most likely not required for immortalization of these cells but rather were selected for during continuous growth in vitro. These findings emphasize the need for caution in the use of hTERT-immortalized cells in studies of normal cell biology or in tissue engineering and the need to monitor for genetic instability and the accumulation of mutations in both the p16INK4a/pRb and p53 pathways.
引用
收藏
页码:3116 / 3121
页数:5
相关论文
共 50 条
  • [1] Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts
    Noble, JR
    Zhong, ZH
    Neumann, AA
    Melki, JR
    Clark, SJ
    Reddel, RR
    ONCOGENE, 2004, 23 (17) : 3116 - 3121
  • [2] Telomere-driven karyotypic complexity concurs with p16INK4a repression in hTERT-immortalized endothelial cells
    Wen, Victoria W.
    Wu, Kaida
    Bakshs, Sheik
    Moore, Malcolm A. S.
    Mackenzie, Karen L.
    CANCER RESEARCH, 2006, 66 (08)
  • [3] The tumor suppressor protein p16INK4a
    Serrano, M
    EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) : 7 - 13
  • [4] p16INK4a and p53 deficiency cooperate in tumorigenesis
    Sharpless, NE
    Alson, S
    Chan, S
    Silver, DP
    Castrillon, DH
    DePinho, RA
    CANCER RESEARCH, 2002, 62 (10) : 2761 - 2765
  • [5] The robe of the p14ARF/p16INK4a/p53 tumor suppressor pathways in laryngeal squamous carcinoma
    Nadal, A
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 162 - 163
  • [6] p16INK4a as a tumor suppressor with therapeutic applicability
    Calbó, J
    Mazo, A
    DRUGS OF THE FUTURE, 2003, 28 (02) : 153 - 166
  • [7] Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms
    Sakajiri, S
    Kawamata, N
    Egashira, M
    Mori, K
    Oshimi, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (10): : 1048 - 1056
  • [8] Deregulation of the tumour suppressor genes p14ARF, p15INK4b, p16INK4a and p53 in basal cell carcinoma
    Kanellou, P.
    Zaravinos, A.
    Zioga, M.
    Spandidos, D. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) : 1215 - 1221
  • [9] p16INK4a modulates p53 in primary human mammary epithelial cells
    Zhang, Jianmin
    Pickering, Curtis R.
    Holst, Charles R.
    Gauthier, Mona L.
    Tlsty, Thea D.
    CANCER RESEARCH, 2006, 66 (21) : 10325 - 10331
  • [10] Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas
    Serrano, J
    Goebel, SU
    Peghini, PL
    Lubensky, IA
    Gibril, F
    Jensen, RT
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11): : 4146 - 4156